Skip to main content

Verona Pharma plc

VRNADelisted Oct 7, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001657312

Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.

13F holders, Q2 2023

Institutional positions in Verona Pharma plc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
105
+10 vs. Q1 2023
Shares held
62.9M
+2.48M (+4.1%) vs. Q1 2023
Total value
$1.33B
+$121.2M (+10.0%) vs. Q1 2023
New holders
21
30 more added
Sold out
11
32 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 105 institutions
Q1 2021: 37 institutionsQ2 2021: 37 institutionsQ3 2021: 40 institutionsQ4 2021: 42 institutionsQ1 2022: 39 institutionsQ2 2022: 40 institutionsQ3 2022: 68 institutionsQ4 2022: 88 institutionsQ1 2023: 95 institutionsQ2 2023: 105 institutionsQ3 2023: 102 institutionsQ4 2023: 117 institutionsQ1 2024: 113 institutionsQ2 2024: 125 institutionsQ3 2024: 150 institutionsQ4 2024: 191 institutionsQ1 2025: 258 institutionsQ2 2025: 292 institutionsQ3 2025: 243 institutionsQ4 2025: 1 institutionQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $1.33B
Q1 2021: $305.1MQ2 2021: $239.9MQ3 2021: $202.7MQ4 2021: $248.0MQ1 2022: $181.7MQ2 2022: $145.9MQ3 2022: $529.0MQ4 2022: $1.31BQ1 2023: $1.21BQ2 2023: $1.33BQ3 2023: $1.07BQ4 2023: $1.35BQ1 2024: $1.08BQ2 2024: $957.0MQ3 2024: $1.95BQ4 2024: $3.19BQ1 2025: $4.58BQ2 2025: $7.18BQ3 2025: $8.57BQ4 2025: $359.0KQ1 2026: $0Q2 2026: $0
Institutions holding VRNA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20251$359.0K
Q3 2025243$8.57B
Q2 2025292$7.18B
Q1 2025258$4.58B
Q4 2024191$3.19B
Q3 2024150$1.95B
Q2 2024125$957.0M
Q1 2024113$1.08B
Q4 2023117$1.35B
Q3 2023102$1.07B
Q2 2023105$1.33B
Q1 202395$1.21B
Q4 202288$1.31B
Q3 202268$529.0M
Q2 202240$145.9M
Q1 202239$181.7M
Q4 202142$248.0M
Q3 202140$202.7M
Q2 202137$239.9M
Q1 202137$305.1M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q1 2023.

Institutions holding VRNA in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Larson Financial Group LLC25$5290.00%00.0%Unchanged
Bell Investment Advisors, Inc56$1.18K0.00%+56New
Impact Partnership Wealth, LLC99$2.09K0.00%+99New
Rhumbline Advisers153$3.23K0.00%+153New
Daiwa Securities Group Inc.244$5.00K0.00%00.0%Unchanged
Tucker Asset Management LLC372$7.86K0.00%−2,074−84.8%Reduced
Federation des caisses Desjardins du Quebec400$8.46K0.00%00.0%Unchanged
Zurcher Kantonalbank (Zurich Cantonalbank)781$16.5K0.00%−200−20.4%Reduced
Plante Moran Financial Advisors, LLC892$18.9K0.00%00.0%Unchanged
Cutler Group LP1,010$21.0K0.00%+730+260.7%Added
Citigroup Inc1,130$23.9K0.00%+407+56.3%Added
Royal Bank of Canada1,575$34.0K0.00%−167−9.6%Reduced
UBS Group AG3,005$63.5K0.00%−2,427−44.7%Reduced
Tower Research Capital LLC (TRC)3,138$66.3K0.00%−1,396−30.8%Reduced
JPMorgan Chase & Co3,153$66.7K0.00%−214,417−98.6%Reduced
Advisor Group Holdings, Inc.4,375$92.5K0.00%+378+9.5%Added
Group One Trading, L.P.8,860$187.3K0.01%+8,860New
Rathbone Brothers plc9,584$202.6K0.00%+9,584New
Bank of Montreal10,000$216.7K0.00%−12,000−54.5%Reduced
Ikarian Capital, LLC313,677$219.2K0.08%+85,000+37.2%Added
Virtu Financial LLC10,910$231.0K0.02%+10,910New
Trexquant Investment LP11,591$245.0K0.01%+11,591New
Commonwealth Equity Services, LLC11,960$253.0K0.00%−11,729−49.5%Reduced
Cahill Wealth Management, LLC12,045$254.6K0.18%00.0%Unchanged
Wells Fargo & Company12,620$266.8K0.00%+12,400+5,636.4%Added
BIT Capital GmbH13,000$274.8K0.03%00.0%Unchanged
Shay Capital LLC13,500$285.4K0.10%00.0%Unchanged
Squarepoint Ops LLC14,008$296.1K0.00%+14,008New
BNP Paribas Arbitrage, SA14,760$312.0K0.00%+3,778+34.4%Added
Voya Investment Management LLC15,970$337.6K0.00%−35,865−69.2%Reduced
Parkwood LLC17,166$363.0K0.07%−1,712−9.1%Reduced
Jane Street Group, LLC17,692$374.0K0.00%+17,692New
State Street Corp17,860$377.6K0.00%−38,019−68.0%Reduced
DekaBank Deutsche Girozentrale20,000$404.0K0.00%00.0%Unchanged
Brinker Capital Investments, LLC19,216$406.2K0.00%+1,125+6.2%Added
Orion Portfolio Solutions, LLC19,216$406.2K0.00%+1,125+6.2%Added
Legato Capital Management LLC19,297$407.9K0.06%+19,297New
China Universal Asset Management Co., Ltd.20,873$441.3K0.14%+20,011+2,321.5%Added
Soleus Capital Management, L.P.21,700$458.7K0.05%+21,700New
Goldman Sachs Group Inc21,946$463.9K0.00%+1,521+7.4%Added
Envestnet Asset Management Inc24,658$521.3K0.00%−30,753−55.5%Reduced
New York State Common Retirement Fund25,953$548.6K0.00%+18,832+264.5%Added
Simplex Trading, LLC27,893$589.0K0.03%+27,893New
Bank of New York Mellon Corp28,510$602.7K0.00%−4,130−12.7%Reduced
Gsa Capital Partners LLP29,432$622.0K0.06%+29,432New
D.A. Davidson & Co.32,500$687.0K0.01%00.0%Unchanged
HighVista Strategies LLC34,027$719.3K0.33%−13,696−28.7%Reduced
Lazard Asset Management LLC37,136$785.0K0.00%+37,136New
Susquehanna International Group, LLP41,647$880.4K0.00%+41,647New
Glenmede Trust Co NA44,480$893.2K0.01%00.0%Unchanged
HAP Trading, LLC43,805$926.0K0.26%+43,805New
Geode Capital Management, LLC44,992$951.1K0.00%+12,202+37.2%Added
SEI Investments Co49,825$1.05M0.00%+4,075+8.9%Added
Boothbay Fund Management, LLC51,284$1.08M0.04%+17,323+51.0%Added
AlphaCentric Advisors LLC55,000$1.16M0.65%00.0%Unchanged
Alps Advisors Inc58,404$1.23M0.01%+8,477+17.0%Added
Legal & General Group Plc61,000$1.29M0.00%+36,624+150.2%Added
Bank of America Corp62,727$1.33M0.00%−14,878−19.2%Reduced
US Bancorp62,825$1.33M0.00%−7,076−10.1%Reduced
Marshall Wace, LLP66,908$1.41M0.00%+66,908New
Morgan Stanley80,928$1.71M0.00%−124,968−60.7%Reduced
UBS Oconnor LLC87,628$1.85M0.04%−9,944−10.2%Reduced
Caption Management, LLC91,562$1.94M0.34%+91,562New
Polar Asset Management Partners Inc.96,500$2.04M0.04%00.0%Unchanged
Ghost Tree Capital, LLC110,000$2.33M0.84%+110,000New
Kennedy Capital Management, Inc.117,072$2.47M0.06%+117,072New
1492 Capital Management LLC141,198$2.98M1.74%+75,359+114.5%Added
Prudential Financial Inc142,749$3.02M0.00%−6,409−4.3%Reduced
Tri Locum Partners LP151,194$3.20M1.19%+53,380+54.6%Added
Caligan Partners LP183,064$3.87M2.35%00.0%Unchanged
Schonfeld Strategic Advisors LLC192,917$4.08M0.04%−142,783−42.5%Reduced
Knoll Capital Management, LLC200,000$4.23M5.18%00.0%Unchanged
Adage Capital Partners GP, L.L.C.218,831$4.63M0.01%−18,100−7.6%Reduced
AXA S.A.254,759$5.39M0.02%+254,759New
Citadel Advisors LLC285,866$6.04M0.01%+17,618+6.6%Added
Two Sigma Advisers, LP288,283$6.09M0.02%+25,483+9.7%Added
Moody Aldrich Partners LLC341,701$7.22M1.40%−9,969−2.8%Reduced
Samsara BioCapital, LLC347,500$7.35M1.29%−347,501−50.0%Reduced
BlackRock Inc.368,560$7.79M0.00%+21,334+6.1%Added
Two Sigma Investments, LP370,675$7.84M0.02%−34,306−8.5%Reduced
Fairmount Funds Management LLC381,939$8.07M1.14%−2,745,490−87.8%Reduced
Parkman Healthcare Partners LLC400,987$8.48M1.47%−87,008−17.8%Reduced
Janus Henderson Group PLC424,556$8.97M0.01%+201,527+90.4%Added
Affinity Asset Advisors, LLC447,667$9.46M3.72%−5,154−1.1%Reduced
Ally Bridge Group (NY) LLC487,631$10.3M12.49%00.0%Unchanged
Woodline Partners LP500,000$10.6M0.13%−1,244,264−71.3%Reduced
Millennium Management LLC533,484$11.3M0.01%−17,278−3.1%Reduced
Bellevue Group AG572,315$12.1M0.17%+309,632+117.9%Added
Paradigm Biocapital Advisors LP893,861$18.9M1.53%−68,500−7.1%Reduced
Avidity Partners Management LP954,500$20.2M0.70%+75,700+8.6%Added
Aisling Capital Management LP1,115,352$23.6M11.55%00.0%Unchanged
Nicholas Investment Partners, LP1,163,355$24.6M1.68%+222,055+23.6%Added
Jennison Associates LLC1,388,663$29.4M0.02%+359,665+35.0%Added
Federated Hermes, Inc.1,670,698$35.3M0.09%+1,268,648+315.5%Added
Carlyle Group Inc.2,457,500$51.9M1.85%00.0%Unchanged
Octagon Capital Advisors LP2,468,000$52.2M7.28%00.0%Unchanged
Frazier Life Sciences Management, L.P.2,944,349$62.2M3.72%00.0%Unchanged
Deep Track Capital, LP3,187,415$67.4M3.15%00.0%Unchanged
OrbiMed Advisors LLC3,777,778$79.9M1.55%−482,913−11.3%Reduced
Vivo Capital, LLC4,249,918$89.8M10.78%00.0%Unchanged